Lindsay Gene Kasper is a Detroit, Michigan based nurse practitioner. Active license number of Lindsay Gene Kasper is 4704303702 in Michigan. Her current practice location is 400 Renaissance Ctr Ste 2600, Detroit. Patients can reach her at 888-731-8994. Lindsay Gene Kasper is FNP-C and her NPI number (Unique professional ID assigned by NPPES) is 1013436427. Lindsay Gene Kasper has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Lindsay Gene Kasper speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1013436427
NPI Enumeration Date:
18 Sep, 2017
NPI Last Update On:
11 Apr, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Lindsay Gene Kasper are as mentioned below.
License Number
Specialization
State
Status
4704303702
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Lindsay Gene Kasper 10405 N Gleaner Rd, Freeland, Michigan
Zip:
48623-9709
Phone Number:
989-737-8814
Patients can reach Lindsay Gene Kasper at 400 Renaissance Ctr Ste 2600, Detroit, Michigan or can call to book an appointment on 888-731-8994.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.